Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 3/20 | 0.44 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.43 |
| ▸ | NPY4R | P50391 | 10/20 | 0.40 |
| ▸ | NPY1R | P25929 | 7/20 | 0.40 |
| ▸ | NPY2R | P49146 | 5/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.39 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27637835 | 1.00 | FOLH1 (0.44) | FOLH1ENPEPNPY4RNPY1RNPY2R | |
| SCHEMBL30197540 | 0.96 | NPY5R (0.43) | FOLH1ENPEPNPY4RNPY1RNPY2R | |
| SCHEMBL30111320 | 0.94 | NPY4R (0.43) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30855541 | 0.94 | NPY4R (0.40) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL6038374 | 0.94 | NPY4R (0.40) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL6038377 | 0.94 | NPY4R (0.40) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31206444 | 0.92 | ENPEP (0.47) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL15011349 | 0.92 | NPY4R (0.40) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL27732271 | 0.92 | NPY4R (0.40) | ENPEPNPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL9614927 | 0.92 | NPY4R (0.40) | ENPEPNPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1720258-A | Tumor targeting agents and uses thereof | KARYON OY (FI) | 2006-01-11 | — | — | CN | disclosed |